Entresto 24 MG-26 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FA24L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,327
Award facts
- Contract value 100% obligated
- $36,326.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,326.74 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) under a firm fixed-price contract. This non-competitive delivery order, finalized on October 31, 2025, with completion targeted for November 3, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Entresto is a cardiovascular medication used in heart failure treatment, reflecting the federal government's ongoing pharmaceutical supply requirements for military and veteran healthcare systems.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting portfolio with the DLA, routinely fulfilling competitively awarded delivery orders for specialty medications, vaccines, and medical supplies across multiple therapeutic domains supporting Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DB26FA24L?
SPE2DB26FA24L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FA24L worth?
The government has obligated $36,327 on SPE2DB26FA24L.
Is contract SPE2DB26FA24L an order under another contract?
Yes. SPE2DB26FA24L is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB26FA24L competed?
The extent of competition for SPE2DB26FA24L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award